Tomasz Szydelko
Overview
Explore the profile of Tomasz Szydelko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karwacki J, Mioskowska A, Tomecka P, Maczka K, Gurwin A, Kobylanski M, et al.
Int Urol Nephrol
. 2025 Mar;
PMID: 40088356
Purpose: This study aimed to evaluate the impact of metastatic lymph nodes (LNs) outside the extended pelvic lymph node dissection (ePLND) template on oncological outcomes, staging, grading, and concomitant parameters...
2.
Krajewski W, Guzinski M, Laszkiewicz J, Tomczak W, Chelmonski A, Grunwald K, et al.
Contemp Oncol (Pozn)
. 2025 Feb;
28(4):335-340.
PMID: 39935758
Introduction: Partial nephrectomy (PN) is the primary treatment for T1 renal cell carcinoma (RCC). Also, percutaneous cryoablation is gaining attention as a curative option in appropriately selected patients. However, even...
3.
Bardowska K, Krajewski W, Kolodziej A, Koscielska-Kasprzak K, Bartoszek D, Zabinska M, et al.
World J Urol
. 2025 Feb;
43(1):114.
PMID: 39928162
Purpose: To prospectively evaluate prognostic capabilities of non-muscle invasive bladder cancer (NMIBC) biomarkers for predicting disease recurrence or progression after radical TURB (transurethral resection of bladder tumor). Methods: Evaluated biomarkers...
4.
Tresh A, Del Giudice F, Li S, Basran S, De Berardinis E, Carino D, et al.
BJUI Compass
. 2025 Jan;
6(1):e481.
PMID: 39877570
Objectives: To assess the impact of a positive history of venous thromboembolism (VTE) on perioperative outcomes, including length of in-hospital stay, readmission rates, 90-day postoperative complications, and healthcare costs in...
5.
Santarelli V, Carino D, Corvino R, Salciccia S, De Berardinis E, Krajewski W, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796651
: Robot-assisted radical prostatectomy (RARP) for the treatment of prostate cancer (PCa) has been standardized over the last 20 years. At our institution, only n = 3 rob arms are...
6.
Guzinski M, Krajewski W, Tomczak W, Nowak L, Laszkiewicz J, Chorbinska J, et al.
Pol J Radiol
. 2025 Jan;
89():e526-e530.
PMID: 39777325
Purpose: The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of...
7.
Laszkiewicz J, De Berardinis E, Krajewski W, Nowak L, Szydelko T, Carino D, et al.
Asian J Androl
. 2024 Dec;
PMID: 39726203
Implantation of inflatable penile prosthesis should be considered as a definitive treatment of erectile dysfunction. However, the sole procedure might not allow for optimal dimensional and functional outcomes. The aim...
8.
Czajkowski M, Malkiewicz B, Czajkowska K, Wierzbicki P, Poterek A, Sosnowski R, et al.
Minerva Urol Nephrol
. 2024 Nov;
PMID: 39570330
Background: Penile cancer is a relatively rare neoplasm in developed countries, with the majority of newly diagnosed cases presenting as organ-confined, with a 5-year survival rate of 90%. Therefore, it...
9.
Szlasa W, Sauer N, Karwacki J, Szewczyk A, Kulbacka J, Szydelko T, et al.
Dent Med Probl
. 2024 Oct;
61(5):713-720.
PMID: 39480959
Background: Avelumab is a human antibody that targets the programmed cell death ligand-1 (PD-L1) protein in cancer cells. Novel anticancer therapies for renal cell carcinoma (RCC) consider cluster of differentiation...
10.
Tomczak W, Krajewski W, Chorbinska J, Nowak L, Grunwald K, Chelmonski A, et al.
World J Urol
. 2024 Oct;
42(1):590.
PMID: 39441344
Purpose: Urolithiasis significantly affects patient quality of life, yet the global standard of care predominantly focuses on achieving a stone free status, often ignoring patient reported outcomes. Currently, there are...